Naohisa Oku

445 citations
16 papers · 399 indexed · h-index 6
Topics
Salivary Gland Tumors Diagnosis and Treatment (6 papers)RNA modifications and cancer (3 papers)Tumors and Oncological Cases (3 papers)
Partner nations
JapanChina

In The Last Decade

Naohisa Oku

14 papers receiving 385 citations

Peers

Naohisa Oku
Comparison fields: 5 of 59
  • Molecular Biology 204
  • Cancer Research 153
  • Oncology 126
  • Neurology 110
  • Cell Biology 39
Replace Fumihito Nakayama with:
Fumihito Nakayama Japan
Bingsheng Sun China
Randall E. Ryan United States
Е. P. Kisseleva Russia
Åsa Franzén Sweden
Burkhard Alber Germany
Jung Hwa Moon South Korea
Sheetal Bhan United States
Daniela R. Macció Argentina
Naohisa Oku relative to Fumihito Nakayama Japan Fumihito Nakayama's profile →
Citations per field
00.5×4.5×
Fumihito Nakayama · 1×
Citations per year

Countries citing papers authored by Naohisa Oku

Since Specialization
Citations

This map shows the geographic impact of Naohisa Oku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naohisa Oku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naohisa Oku more than expected).

Fields of papers citing papers by Naohisa Oku

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naohisa Oku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naohisa Oku. The network helps show where Naohisa Oku may publish in the future.

Co-authorship network of co-authors of Naohisa Oku

This figure shows the co-authorship network connecting the top 25 collaborators of Naohisa Oku. A scholar is included among the top collaborators of Naohisa Oku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naohisa Oku. Naohisa Oku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 85
2 2
3 196
4 3
5 13
6
Establishment of in vivo metastasis model of human adenoid cystic carcinoma: detection of metastasis by PCR with human beta-globin gene.
5
7 14
8 1
9 1
10 1
11
Establishment of a novel human squamous cell carcinoma cell line from oral primary tumor by geneticin treatment.
2
12 5
13 1
14 1
15 3
16 66

About Naohisa Oku

Naohisa Oku is a scholar working on Otorhinolaryngology, Oral Surgery and Oncology, having authored 16 papers that have together received 399 indexed citations. Recurring topics across this work include Salivary Gland Tumors Diagnosis and Treatment (6 papers), RNA modifications and cancer (3 papers) and Tumors and Oncological Cases (3 papers). The work is most often cited by research in Neurology (110 citations), Cancer Research (153 citations) and Immunology and Allergy (29 citations). Naohisa Oku has collaborated with scholars based in Japan and China. Frequent co-authors include Eri Sasabe, Tokio Osaki, Eisaku Ueta, Tetsuya Yamamoto, Tetsuya Yamamoto, Xuan Zhou, Dechao Li, Yuichi Hori, Kozo Kaibuchi and Yoshimi Takai. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026